Cameron Dermatology

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Hidradenitis suppurativa2 trials
• Psoriasis2 trials

Phase

• Phase 34 trials

Status

• Active, not recruiting2 trials
• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Alumis Inc2 trials
• Novartis Pharmaceuticals2 trials

Running trials

• Recruiting

  An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS

  NCT07665437· Phase 3· Novartis Pharmaceuticals· Source

  Contact: Yamiles Gonzalez

• Active, not recruiting

  A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa

  NCT06840392· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis

  NCT06846541· Phase 3· Alumis Inc· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Hidradenitis suppurativa1 recruiting

Closed trials

• Completed

  A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

  NCT06588738· Phase 3· Alumis Inc· Source